Lionsgate Studios Fiscal Q2 2027 Revenue Tops Estimates at $724.3M, but EPS Misses at -$0.16
Revenue of $724.3M vs. $628.8M expected and adjusted EPS of -$0.16 vs. -$0.03.
Lionsgate Studios (LION) posted mixed fiscal second-quarter 2027 results, with revenue above the estimate and adjusted EPS below it. Revenue was $724.3 million above the $628.8 million estimate, and adjusted EPS was -$0.16 below the -$0.03 estimate.
Fiscal Q2 2027 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | -$0.03 | -$0.16 | Miss by 529% |
| Revenue | $628.8M | $724.3M | Beat by 15% |
| Change | QoQ |
|---|---|
| Adjusted EPS | ▼ from $0.06 |
| Revenue | ▼ 6.7% |
By our calculation, revenue was $95.5 million above the estimate and adjusted EPS was $0.13 below it. The QoQ column compares with the previous quarter's revenue of $776.6 million and adjusted EPS of $0.06.
Track record
- EPS record. Adjusted EPS beat the estimate in 2 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 5 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $724.3 million, $906.5 million, $776.6 million, $776.6 million and $724.3 million.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.06 and revenue of $681.0 million next quarter, based on 1 analyst.
- Estimate record. Whether Lionsgate Studios returns to beating EPS estimates, which it did in 2 of its last 8 reports.
- Sequential trend. Whether revenue builds on its 6.7% decrease from the previous quarter.
- Related coverage. See our reports on Dianthus Therapeutics, Titan America, Personalis and Nutrien.
Sources: Results are from Lionsgate Studios's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Lionsgate Studios's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Dianthus Therapeutics Beats Q3 2026 Estimates as Revenue Rises 206% to $1.2M
EarningsTitan America Misses Q3 2026 Estimates as Revenue Rises 5.7% to $461.6M
EarningsPersonalis Q3 2026 Revenue Tops Estimates at $25.6M, but EPS Misses at -$0.32
EarningsNutrien Q3 2026 Revenue Tops Estimates at $5.69B, but EPS Misses at $0.61
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
